Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation
- Patrick C Souverein
- , Hendrika A van den Ham
- , Consuelo Huerta
- , Elisa Martín Merino
- , Dolores Montero
- , Luz M León-Muñoz
- , Sven Schmiedl
- , Andreas Heeke
- , Marietta Rottenkolber
- , Morten Andersen
- , Mia Aakjaer
- , Marie L De Bruin
- , Olaf H Klungel
- , Helga Gardarsdottir
- Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.
- Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
- AOK NORDWEST, Dortmund, Germany.
- Diabetic Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universitaet Muenchen, Munich, Germany.
- Pharmacovigilance Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Research output: Contribution to journal › Article › Academic › peer-review